Idea principal
Among 191 pre-frail adults aged 65 or older, the highest tertile of fat-free mass index (FFMI) went with better physical function, higher cognitive scores and lower odds of sarcopenia after adjustment, while higher BMI was associated with lower odds of sarcopenia. The abstract gives no effect sizes, and the study is cross-sectional and small.
Study design
Artículo de investigación
Reading basis
Published abstract
Reading focus
Design & applicability
Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.
Pregunta de investigación
BMI cannot tell fat from muscle or show where fat is stored, so it may mislead in older people. The authors first assessed how BMI relates to fat mass index (FMI), fat-free mass index (FFMI) and the ratio of fat mass to fat-free mass (FM/FFM), then asked how those measures relate to physical function, sarcopenia and cognition in pre-frail older adults.
Población y método
Cross-sectional study of 191 pre-frail participants aged 65 or older (57.1% female). The team collected demographics, cognition with the Montreal Cognitive Assessment (MoCA), function, frailty, calf circumference, handgrip strength (HGS), the short physical performance battery (SPPB) and gait speed. Body composition was measured with an InBody S10. FMI, FFMI and FM/FFM were each split into tertiles (T1 lowest, T3 highest) and compared with stratification by BMI. The abstract does not name the covariates in the adjusted analysis.
Resultados
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1In the high BMI group, higher FFMI and lower FM/FFM were associated with better functional outcomes, and low muscle mass was more prevalent in the normal BMI group.
- 2FMI and FM/FFM were significantly higher in females and FFMI in males; the sex difference held at all ages except for FFMI in people 80 or older.
- 3The highest FMI and FM/FFM tertiles had significantly higher sarcopenic obesity and worse grip strength, gait speed and SPPB scores. Small calf circumference was significantly less common in the highest tertile of FMI, FM/FFM and FFMI.
- 4The highest FFMI tertile had better physical function, higher MoCA scores and less sarcopenic obesity and sarcopenia. After adjustment, it was associated with lower odds of sarcopenia, especially in the high BMI group, whereas the highest FM/FFM tertile was associated with higher odds of sarcopenia. Higher BMI was associated with lower odds of sarcopenia.
Límites e incertidumbre
- 1Only 191 pre-frail people were studied at one time point, so the design cannot show whether lean mass preserves function or fitter people simply carry more lean mass.
- 2The abstract reports no odds ratios, confidence intervals or P values for most comparisons, so how strong or precise the associations are cannot be judged.
- 3Body composition came from a single bioimpedance device (InBody S10), and the authors say the BMI cut-offs and the use of calf circumference as a screening tool need validating in larger populations. This reading is based on the abstract only.
Relevancia práctica
Two people with the same BMI can have very different mixes of fat and muscle, and in this group more lean mass relative to height went with better function. The findings do not prove that building muscle prevents sarcopenia, and no one should chase a higher BMI because of them. A clinician can advise on nutrition and strength exercise for older adults.
Tus datos
Smart scales and body-composition devices estimate fat-free mass, but impedance readings shift with hydration, meals and time of day. Measure under the same conditions, such as in the morning before eating, and follow the trend over months alongside grip or sit-to-stand tests rather than single values.
Cómo interpretar la evidencia
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Resumen estructurado de los autores English
El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.
Background
Body mass index (BMI) is an inadequate marker of obesity, and cannot distinguish between fat mass, fat free mass and distribution of adipose tissue. The purpose of this study was twofold. First, to assess cross-sectional relationship of BMI with fat mass index (FMI), fat free mass index (FFMI) and ratio of fat mass to fat free mass (FM/FFM). Second, to study the association of FMI, FFMI and FM/FFM with physical function including sarcopenia, and cognition in pre-frail older adults.
Methods
Cross-sectional study of 191 pre-frail participants ≥ 65 years, 57.1% females. Data was collected on demographics, cognition [Montreal Cognitive Assessment (MoCA)], function, frailty, calf circumference, handgrip strength (HGS), short physical performance battery (SPPB) and gait speed. Body composition was measured using InBody S10. FMI, FFMI and FM/FFM were classified into tertiles (T1, T2, T3) with T1 classified as lowest and T3 highest tertile respectively and stratified by BMI.
Results
Higher FFMI and lower FM/FFM in the high BMI group were associated with better functional outcomes. Prevalence of low muscle mass was higher in the normal BMI group. FMI and FM/FFM were significantly higher in females and FFMI in males with significant gender differences except for FFMI in ≥ 80 years old. Small calf circumference was significantly less prevalent in the highest tertile of FMI, FM/FMI and FFMI. Prevalence of sarcopenic obesity and low physical function (HGS, gait speed and SPPB scores) were significantly higher in the highest FMI and FM/FFM tertile. Highest FFMI tertile group had higher physical function, higher MoCA scores, lower prevalence of sarcopenic obesity and sarcopenia, After adjustment, highest tertile of FFMI was associated with lower odds of sarcopenia especially in the high BMI group. Highest tertile of FM/FFM was associated with higher odds of sarcopenia. Higher BMI was associated with lower odds of sarcopenia.
Conclusion
FFMI and FM/FFM may be a better predictor of functional outcomes in pre-frail older adults than BMI. Cut-off values for healthy BMI values and role of calf circumference as a screening tool for sarcopenia need to be validated in larger population. Health promotion intervention should focus on FFMI increment.
Fuentes y atribución
Relationship of Fat Mass Index and Fat Free Mass Index With Body Mass Index and Association With Function, Cognition and Sarcopenia in Pre-Frail Older Adults.
Merchant RA, Seetharaman S, Au L, Wong MWK, Wong BLL, Tan LF, Chen MZ, Ng SE, Soong JTY, Hui RJY, Kwek SC, Morley JE.
Frontiers in endocrinology · 2021-12-24
DOI: 10.3389/fendo.2021.765415 ↗PubMed · 35002957 ↗Europe PMC · Licencia registrada: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada
Fuentes verificadas 2026-11-01
Guías prácticas
Leer en contexto
ACSM review of 137 reviews: resistance training works, and few programme details matter
The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.
Medicine & Science in Sports & Exercise
Nearly every resistance training plan beat no exercise; heavy loads led for strength
In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.
British Journal of Sports Medicine
Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes
Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.
British Journal of Sports Medicine
Protein supplements and weight training: small extra gains, smaller in older adults
Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.
British Journal of Sports Medicine

